Top compounds associated with response to RGMA


Feature Type Standardized
Nominal ANOVA
mRNA PRIMA-1-Met CTRPv2 pan-cancer AAC 0.16 0.002
mRNA ML312 CTRPv2 pan-cancer AAC 0.37 0.002
mRNA BRD-K27188169:navitoclax (2:1 mol/mol) CTRPv2 pan-cancer AAC 0.16 0.002
mRNA JW-7-24-1 GDSC1000 pan-cancer AAC 0.09 0.002
mRNA THZ-2-102-1 GDSC1000 pan-cancer AAC 0.092 0.002
mRNA tubastatin A GDSC1000 pan-cancer AAC 0.093 0.003
mRNA UNC0638:navitoclax (1:1 mol/mol) CTRPv2 pan-cancer AAC 0.11 0.003
mRNA CX-5461 GDSC1000 pan-cancer AAC 0.094 0.003
mRNA navitoclax:MST-312 (1:1 mol/mol) CTRPv2 pan-cancer AAC 0.1 0.004
mRNA tretinoin:navitoclax (4:1 mol/mol) CTRPv2 pan-cancer AAC 0.098 0.004
Download CSV